Article

LUNGevity Foundation Launches Inhale for Life: Find it Early and Live Public Service and Social Media Campaign During Lung Cancer Awareness Month

Medical experts and people living with lung cancer share the importance of early detection of lung cancer to ensure optimal patient outcomes.

WASHINGTON, Nov. 4, 2021 /PRNewswire/ -- LUNGevity, the nation's leading lung cancer-focused nonprofit organization, is kicking off Lung Cancer Awareness Month with the launch of its Inhale for Life: Find it Early and Live public service campaign. This powerful campaign features the stories of lung cancer survivors whose cancer was diagnosed at stage I, when it is most treatable, greatly increasing their chance of survival. In fact, these survivors are living normal lives.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8883051-lungevity-inhale-for-life-find-it-early-and-live-lung-cancer-psa/

Inhale for Life: Find it Early and Live is the fifth annual campaign in LUNGevity's Inhale for Life educational video and social media-driven series. This installment aims to educate people with a longtime smoking history to find out if they are eligible for a low-dose CT screen, which can find their lung cancer at its earliest stage, when it is most treatable and even curable. Patients who were able to have surgery to remove their lung cancer when it was found early due to screening share their stories and their current active lifestyles.

The videos also explain why it is crucial to support research into new noninvasive, universal early detection tests that will discover all lung cancers, in smokers and nonsmokers alike. The survivors shown who were diagnosed because of unrelated circumstances help drive home the message that lung cancer should not be found by accident.

"Detecting lung cancer early, when it is easiest to treat, can save lives," says Andrea Ferris, president and CEO of LUNGevity Foundation. "Today, only 18% of lung cancers are diagnosed at an early stage, and many patients are diagnosed when they experience symptoms, when the cancer is most likely in a more advanced stage. Our goal with Inhale for Life: Find it Early and Live is to get eligible patients screened and to push for support for new modes of early detection so that more lung cancer patients will have a chance for a cure."

The Inhale for Life: Find it Early and Live videos showcase six lung cancer survivors who were screened for lung cancer or whose cancer was found during screening for unconnected medical issues. Also featured are two renowned medical experts who speak on the importance of early detection in lung cancer: Robert Winn, MD, director of VCU Massey Cancer Center and a member of the LUNGevity Board of Directors, and Avrum Spira, MD, MSCI, global head of the Johnson & Johnson Lung Cancer Initiative, professor of medicine at Boston University, and a member of the LUNGevity Scientific Advisory Board.

The Inhale for Life: Find it Early and Live campaign is supported in part by grants from AstraZeneca, Genentech, Bristol Myers Squibb, Regeneron, and Sanofi Genzyme.

The campaign can be seen at lungevity.org/inhale-for-life-early-detection.

About LUNGevity Foundation

LUNGevity Foundation is the nation's leading lung cancer organization focused on improving outcomes for people with lung cancer through research, education, policy initiatives, and support and engagement for patients, survivors, and caregivers. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the disease—while promoting health equity by addressing disparities throughout the care continuum. LUNGevity works tirelessly to advance research into early detection and more effective treatments, provide information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivors—and those who help them live longer and better lives.

Comprehensive resources include a medically vetted and patient-centric website, a toll-free HELPLine for support, the International Lung Cancer Survivorship Conference, and an easy-to-use Clinical Trial Finder, among other tools. All of these programs are to achieve our vision—a world where no one dies of lung cancer. LUNGevity Foundation is proud to be a four-star Charity Navigator organization.

Please visit lungevity.org to learn more.

About Lung Cancer in the US

  • About 1 in 16 Americans will be diagnosed with lung cancer in their lifetime.
  • More than 235,000 people in the US will be diagnosed with lung cancer this year.
  • About 60%-65% of all new lung cancer diagnoses are among people who have never smoked or are former smokers.
  • Lung cancer takes more lives than the next three leading cancers (colorectal, breast, and prostate) combined.
  • Only 22% of all people diagnosed with lung cancer will survive 5 years or more, BUT if it's caught before it spreads, the chance of 5-year survival improves dramatically.
Related Videos
Dr. Upal Basu Roy
Katie Brown
Dr. Upal Basu Roy
Dr. Upal Basu Roy
Katie Brown
Related Content
Illustration of a pair of lungs with a tumor.
August 9th 2024

ctDNA-Guided Treatment De-escalation Feasible in Advanced NSCLC

Alex Biese
One expert explains how a break in TKI treatment could alleviate some toxicities, such as rash, for patients with non-small cell lung cancer.
9/11 and Cancer: Health Impacts Remain 20 Years Later
September 7th 2021

9/11 and Cancer: Health Impacts Remain 20 Years Later

Brielle Benyon
Soon after the 9/11 terrorist attacks, Judy Meyers returned to work in Manhattan, despite the terrible air quality. Years later, she was diagnosed with lung cancer, which is directly related to being in New York City in the aftermath of the destruction of the Twin Towers.
Image of a tumor in the right lung.
April 30th 2024

‘Landmark’ Findings Led to Alecensa Approval for ALK-Positive NSCLC

Alex Biese
Alecensa was shown to reduce the risk of disease recurrence or death by 76% versus chemotherapy for patients with ALK-positive non-small cell lung cancer.
Image of an x-ray with an emphasis on the lungs in red. A zoom in on small cell lung cancer.
March 5th 2024

Small Cell Lung Cancer: It’s a Time to Be Hopeful

Alex Biese
Patients with small cell lung cancer have reasons to be optimistic these days, as one expert explains to CURE.
Michele Altizer, right, with her youngest son, JAKE, left. The mother of three received a diagnosis of lung cancer after developing a cough and shortness of breath. Photo credit: MOON REFLECTIONS PHOTOGRAPHY
November 6th 2023

Lowering Doses to Increase Quality of Life in Lung Cancer

Darlene Dobkowski, MA
Managing side effects from lung cancer treatment with dose reductions is an approach experts have been using more, even though some patients voice concerns about lowering a drug’s impact on the disease.
What Patients With Lung Cancer Don’t Know May Be Critically Important
April 14th 2022

What Patients With Lung Cancer Don’t Know May Be Critically Important

Colleen Moretti
Patients who are part of an advocacy group may be better equipped to understand biomarker testing during a lung cancer diagnosis and feel more empowered.